Cargando…

Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers

Medullary thyroid carcinoma (MTC) is a rare calcitonin producing neuroendocrine tumour that originates from the parafollicular C-cells of the thyroid gland. The RET proto-oncogene encodes the RET receptor tyrosine kinase, with consequently essential roles in cell survival, differentiation and prolif...

Descripción completa

Detalles Bibliográficos
Autores principales:	A, Taccaliti, F, Silvetti, G, Palmonella, M, Boscaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271314/ https://www.ncbi.nlm.nih.gov/pubmed/22654561 http://dx.doi.org/10.2174/138920211798120835

Ejemplares similares

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
por: Werner, R.A., et al.
Publicado: (2015)

Development and validation of prognostic nomograms for medullary thyroid cancer
por: Guan, Yong-jun, et al.
Publicado: (2019)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
por: Mondin, Alberto, et al.
Publicado: (2023)

Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
por: Gómez Sáez, José M
Publicado: (2011)

The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
por: Gawlik, Tomasz, et al.
Publicado: (2010)

Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma
por: Li, Canxiao, et al.
Publicado: (2022)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

Prognostic significance and optimal cutoff of age in medullary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2016)

Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia
por: Martino, Marianna, et al.
Publicado: (2021)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum
Publicado: (2016)

Shear wave elastography in medullary thyroid carcinoma diagnostics
por: Dobruch-Sobczak, Katarzyna, et al.
Publicado: (2015)

Diagnostic tests for medullary thyroid carcinoma: an umbrella review
por: Trimboli, Pierpaolo, et al.
Publicado: (2023)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Characterization of Human Medullary Thyroid Carcinoma Glycosphingolipids Identifies Potential Cancer Markers
por: Säljö, Karin, et al.
Publicado: (2021)

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells
por: Bertazza, Loris, et al.
Publicado: (2015)

The Genetic Aspects of Medullary Thyroid Carcinoma: Recognition and Management
por: Williamson, Paula, et al.
Publicado: (1996)

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)
por: Diquigiovanni, Chiara, et al.
Publicado: (2021)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

Activity of roniciclib in medullary thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2018)

A Benign Medullary Thyroid Cancer
por: Pishdad, Reza, et al.
Publicado: (2022)

Neoadjuvant selpercatinib for advanced medullary thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2020)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft’s Function and Predict Survival after Liver Transplantation
por: Nicolini, Daniele, et al.
Publicado: (2015)

Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
por: Magnani, P., et al.
Publicado: (1996)

How I treat medullary thyroid cancer
por: Kiesewetter, B., et al.
Publicado: (2021)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer
por: Parikh, Rohan, et al.
Publicado: (2022)

Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer
por: Hao, Weijing, et al.
Publicado: (2023)

Medullary Thyroid Cancer: It is a pain in the neck?
por: Guerrero, Marlon A., et al.
Publicado: (2011)

Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma
por: Koch, Christian A, et al.
Publicado: (2006)

Allel RET+3 : T a medullary thyroid cancer
por: Pławski, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f3jd55q2971tjqq30hosvj2lbq